Dépistage du déficit en dihydropyrimidine déshydrogénase (DPD) et sécurisation des chimiothérapies à base de fluoropyrimidines : mise au point et recommandations nationales du GPCO-Unicancer et du RNPGxMarie‐Anne Loriot, Marie-Christine Étienne-Grimaldi, Chantal Barin‐Le Guellec et al.|Bulletin du Cancer|2018Cited by 108
Deciphering Tumour Heterogeneity: From Tissue to Liquid BiopsyPauline Gilson, Alexandre Harlé|Cancers|2022Cited by 108
Representative Sequencing: Unbiased Sampling of Solid Tumor TissueKevin Litchfield, Ron Sinclair, Stuart Horswell et al.|Cell Reports|2020Cited by 77
Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targetsShuhui Chen, Alexandre Harlé|Oncology Letters|2016Cited by 20
579P A multicenter evaluation of a low pass whole genome sequencing-based solution for homologous recombination deficiency detectionA. Buisson, I. Ray-Coquard, Alexandre Harlé et al.|Annals of Oncology|2022Cited by 1